Substituted Benzofuran Synthesis via Pd-Catalyzed Cross-Coupling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing substituted benzofuran tubulin polymerization inhibitors on a kilogram scale are inefficient and challenging, limiting the production of compounds with promising anti-proliferative activity.
Innovation Solution
A method involving coupling a compound with an alkyne in the presence of a palladium catalyst, followed by reaction with a compound in the presence of CO at temperatures below 50°C, and subsequent removal of the hydroxy protecting group and conversion to a disodium phosphate ester, to efficiently produce kilogram quantities of compounds with high purity and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional laboratory-scale synthesis methods are used, then the synthesis can be performed with standard procedures, but the production cannot be efficiently scaled to kilogram quantities
Solution Approach 1:
The synthesis is divided into distinct modular stages: (i) coupling of compound (2) with alkyne (3) using Pd-catalyzed cross-coupling, (ii) in-situ reaction with compound (4) under CO atmosphere at controlled temperature, and (iii) deprotection and phosphate ester formation. Each stage is optimized independently to enable scalable production while maintaining efficiency.
Solution Approach 2:
The hydroxy group is protected in advance with protecting group P before the coupling reaction, preventing unwanted side reactions during the palladium-catalyzed steps. This preliminary protection enables cleaner reactions and simplifies downstream processing at kilogram scale.
2Productivity
If synthesis is performed on kilogram scale, then sufficient quantities for pharmaceutical development are obtained, but purification requirements increase and regulatory compliance becomes more challenging
Solution Approach 1:
The reaction conditions are designed to minimize the formation of impurities that would require chromatographic purification. The controlled temperature below 50°C during the carbonylation step and the specific reagent combinations reduce side-product formation, allowing kilogram-scale production with acceptable purity levels that meet regulatory standards without extensive purification.
Solution Approach 2:
The reaction temperature is strictly controlled below 50°C during the carbonylation step to optimize selectivity and minimize by-product formation. This parameter control ensures high product purity while maintaining efficient reaction rates suitable for scaled-up production.
3Manufacturing precision
If chromatographic purification is used to achieve high purity, then product quality is improved, but production time and cost increase
Solution Approach 1:
The synthesis route is specifically designed to minimize impurity formation through careful selection of reagents and reaction conditions, thereby reducing or eliminating the need for chromatographic purification steps. This approach maintains high product purity while significantly improving production efficiency and reducing costs.
4Productivity
If heavy metal catalysts are used for efficient coupling, then reaction efficiency is improved, but regulatory compliance for pharmaceutical products becomes more difficult
Solution Approach 1:
The palladium catalyst is used at optimized concentrations and under controlled reaction conditions to maximize coupling efficiency while minimizing residual metal content in the final product. The subsequent deprotection and phosphate ester formation steps are designed to facilitate removal of trace heavy metals, ensuring compliance with pharmaceutical regulatory standards.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the efficient production of kilogram quantities of substituted benzofurans with high purity and yield, minimizing the need for chromatographic purification and ensuring compliance with regulatory standards for heavy metal content in pharmaceuticals.
Implementation Method 1
coupling a compound of formula (2) with an alkyne of formula (3) in the presence of a palladium catalyst
Implementation Method 2
reacting in situ the resultant coupled product of step a) with a compound of formula (4) wherein R2 is Br, I or CF3SO3, in the presence of CO at a temperature below 50° C.
Data Source
AI summary
The present invention relates to the scaled-up synthesis of biologically active compounds which display useful therapeutic activity in treating proliferative disorders. In particular the invention relates to process methods for the kilogram scale synthesis of a particular class of substituted benzofuran tubulin polymerisation inhibitors.